Reaction
Sle Arthritis reporting signals
As of the last recalculation, Sle Arthritis appears in 282 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is BELIMUMAB (PRR 283.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Belimumab | 85 | 283.2 | 284.0 |
| Tobramycin Solution | 16 | 104.2 | 104.3 |
| Tobramycin Sulfate | 16 | 101.1 | 101.2 |
| Azathioprine | 84 | 99.8 | 99.9 |
| Hydroxychloroquine Sulfate | 66 | 69.5 | 69.6 |
| Abatacept | 81 | 60.2 | 60.2 |
| Tobramycin | 16 | 52.0 | 52.0 |